){kind=logo}
This is a past event, catch up below
Innovative medicines provide the opportunity to transform patient care, pathways, and outcomes. But how do we improve access and uptake of these medicines in a way that is affordable, and that supports the already overstretched health and care workforce.
This free online event was an opportunity to consider some of the key challenges to access and uptake of innovative medicines in England. We discussed:
the current barriers to improving access to new medicines
how to build on experiences and lessons from the rapid development, approval and rollout of vaccines and treatments as response to the Covid-19 pandemic.
We also considered what more could be done to address inequalities in uptake – especially in areas such as rare disease – and how to support and engage with an already overstretched workforce to improve uptake. Speakers discussed:
patients’ experiences, including how to address issues with variation in access and care
how we realise the potential of innovative medicine in the light of the frontline challenges NHS clinicians and patients are facing and engage in the development of new models of care to facilitate uptake.
Watch back on demand
Event sponsorship
Get in touch about sponsorship and exhibition
If you would like a conversation about your business goals, and how being involved with future events can help you, please email the Partnerships team.
Speakers
-
)
Samantha Barber
Chief Executive, Gene People -
)
Louise Fish
Chief Executive, Genetic Alliance -
)
Richard Murray
Former Chief Executive -
)
Guy Oliver
General Manager, UK and Ireland, Ipsen -
)
Sharmila Nebhrajani OBE
Chairman, NICE -
)
Dr Richard Roope
Wessex Rapid Investigation Service GP and Wessex Cancer Alliance GP Adviser